UW–Madison To Perform the First U.S. Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors
November 21 2022 - 01:29PM
Business Wire
- GE Healthcare’s design for Deep Silicon detectors for a photon
counting CT (PCCT) is engineered with the goal of achieving
breakthroughs in both CT spatial and spectral resolution at the
same time and increasing imaging performance across care areas
- Researchers at the University of Wisconsin–Madison will kick
off research scanning human subjects with GE Healthcare’s latest
generation PCCT prototype in December 2022, representing the first
U.S. clinical evaluation site with GE Healthcare’s pure silicon CT
detector technology
- The project is the result of a close collaboration between
Wisconsin-based healthcare, academia and medical technology
providers
Researchers at the University of Wisconsin–Madison, the first
U.S. clinical evaluation site for GE Healthcare’s industry-first
silicon-based photon counting CTi, will begin human scanning using
the device, which is engineered with Deep Silicon detectors with
the goal of greatly enhancing imaging capabilities to help
clinicians improve patient outcomes across oncology, cardiology,
neurology, and other clinical CT applications.
The collaboration comes nearly one year after GE Healthcare
announced its first clinical evaluation site at Karolinska
Institute and MedTechLabs in Sweden. Since then, the company has
made rapid progress in enhancing the developing technology,
building a new system prototype to include:
- A larger detector with the possible goal of enabling quicker
scan times as well as expanding coverage;
- ECG-gated cardiac scan capabilities designed for coronary
artery imaging; and
- Faster acquisition speed with the intent to reduce the
likelihood of blurred images due to motionii.
“Photon counting CT has promise to embody the best of CT imaging
available to date,” explains Dr. Meghan G Lubner, professor of
radiology at the UW School of Medicine and Public Health. “This
technology has the potential to expand the scope of current
indications by combining refined energy resolved data, high spatial
resolution, reduced noise and improved soft tissue contrast. We are
working with GE Healthcare by testing their novel photon counting
solutions in human subjects to assess issues ranging from improving
commonly encountered CT image quality limitations to evaluating
whether previously out of reach clinical questions can now feasibly
be answered.”
Photon counting CT could potentially advance the capabilities of
CT, including the visualization of minute details of organ
structures, improved tissue characterization, more accurate
material density measurement (or quantification) and lower
radiation dose.
GE Healthcare is pursuing a unique approach to photon counting
CT, which may enable higher spatial and spectral resolution at the
same time, thanks to several advantages provided by Deep Silicon
detectors, including: the detector’s material purity, innovative
geometric design, and true multi-bin technologies for high
performance spectral imaging. As such, the research being done at
UW–Madison will assist GE Healthcare in better understanding the
heights of these unique capabilities.
“Photon counting detectors push CT technology forward in two
major ways: better spatial resolution and better contrast
resolution,” shares Tim Szczykutowicz, Ph.D., associate professor
radiology at the school. Szczykutowicz is also affiliated with the
Departments of Medical Physics and Biomedical Engineering. “I think
for CT, photon counting is undoubtedly the next big thing. We are a
part of the process of evaluating and developing this unique
approach to photon counting based on Deep Silicon technology.”
UW–Madison will facilitate human subject research and produce
technical feedback to test and advance GE Healthcare’s photon
counting CT technology with Deep Silicon. The study will assess
reconstruction methods, image presentation workflows, and clinical
benefits for specific pathologies and disease types to determine
how to best optimize photon counting CT with Deep Silicon detectors
to enable better visualization and utilization.
“Innovation requires close collaboration between medical
technology innovators and academia,” concludes Jean-Luc Procaccini,
President & CEO, Molecular Imaging & Computed Tomography,
GE Healthcare. “We are thrilled to deliver our newest prototype to
our long-time collaborators at UW–Madison and UW Health. Together
with UW, Karolinska Institute and MedTechLabs, we are advancing a
cutting-edge technology with the potential to provide clinicians
and patients with more information sooner – all with the goal of
helping to improve patient outcomes.”
For more information on GE Healthcare’s unique approach to
photon counting CT with Deep Silicon, visit gehealthcare.com.
About GE Healthcare:
GE Healthcare is the $17.7 billion healthcare business of GE
(NYSE: GE). As a leading global medical technology, pharmaceutical
diagnostics and digital solutions innovator, GE Healthcare enables
clinicians to make faster, more informed decisions through
intelligent devices, data analytics, applications and services,
supported by its Edison intelligence platform. With over 100 years
of healthcare industry experience and around 48,000 employees
globally, the company operates at the center of an ecosystem
working toward precision health, digitizing healthcare, helping
drive productivity and improve outcomes for patients, providers,
health systems and researchers around the world.
Follow us on Facebook, LinkedIn, Twitter, Instagram and Insights
for the latest news, or visit our website www.gehealthcare.com for
more information.
i Technology in development that represents ongoing research and
development efforts. These technologies are not products and may
never become products. Not for sale. Not cleared or approved by the
U.S. FDA or any other global regulator for commercial availability.
Not CE marked. ii Compared to previous prototype version.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221121005797/en/
Margaret Steinhafel Chicago margaret.steinhafel@ge.com +1 608
381 8829
General Electric (NYSE:GE)
Historical Stock Chart
From May 2023 to Jun 2023
General Electric (NYSE:GE)
Historical Stock Chart
From Jun 2022 to Jun 2023